Methylprednisolone alone or combined with cyclosporine or mycophenolate mofetil for the treatment of immune‐mediated hemolytic anemia in dogs, a prospective study
Mycophenolate
DOI:
10.1111/jvim.17122
Publication Date:
2024-07-04T04:40:03Z
AUTHORS (8)
ABSTRACT
Abstract Background Benefit of adding a second‐line immunosuppressive drug to glucocorticoids for the treatment non‐associative immune‐mediated hemolytic anemia (naIMHA) in dogs has not been defined prospectively. Hypothesis/Objectives Evaluate effectiveness different protocols naIMHA dogs. Animals Forty‐three client‐owned Methods Open label, randomized, clinical trial. Dogs were treated with methylprednisolone (M‐group), plus cyclosporine (MC‐group) or mycophenolate mofetil (MM‐group). as responders by disappearance signs destruction and hematocrit stabilization. Frequency was compared between M‐group combined (MC MM‐group evaluated together), among 3 therapeutic groups at 14 (T14), 30 (T30), 60 (T60) days after admission. complications, length hospitalization relapse also compared. Death rate discharge, T60 365 (T365) days. Results Proportion significantly MM‐groups), nor T14, T30, ( P > .17 ). relapse, protocols, (P .22). more common only MC‐group (+42.8%; 95% CI: 11.5–67.4; = .009), T365 (+50%; 17.5–73.2; .003). Conclusions Clinical Importance Combined therapy did improve hematological response naIMHA.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (64)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....